Predictive data to preserve health
Delivering and exploiting data for cardiac decompensation prevention
Our mission
Providing actionable data to maintain cardiac condition stability
Keep patients at home
Delay the loss of autonomy
Reduce avoidable hospital admissions
At CardiaMetrics, we want to provide telemedicine platforms and physicians with early data to prevent cardiac decompensations and adjust medications to maintain the stability of the cardiac function.
This solution addresses chronic heart failure patients and those undergoing cardiotoxic drugs for cancer treatment.
Heart failure burden
64 million people worldwide
1 in 5 people aged 70-85 years have HF
1,270,360 hospitalizations / year (in 2018)
$30.7 billion in 2012 to 69.7 billion in 2030
Our Solution
A best-of-breed medical monitoring system utilizing subcutaneous sensors that collect and transmit vital physiological data daily.
This IoT-enabled solution provides combined and aggregated hemodynamic and electrophysiological data to remote monitoring platforms, enabling proactive and personalized patient care by giving clinicians regular, remote insights into key biological metrics.
Additionally, our solution allows for the identification and prioritization of individuals who require immediate intervention or preventive therapeutic adjustments, thereby increasing the productivity of healthcare teams by streamlining workflows and focusing resources where they are needed most.
Creating a meaningful impact
For healthcare system
Enlarge market and allow scalability
- Increasing efficiency thanks to daily and reliable data
- Prioritizing patients at risk to reduce time waste, allowing to take care of more individuals
- Expanding the accessible Market with a solution suitable for patients who can’t or don’t want to engage in self-care management
For patients
Ensure Stability and provide personnalized care
- Avoiding crises by early optimization of treatments
- Decreasing the mental burden of the disease by providing a fully automatic solution
- Patient empowerment through effective therapeutic education personalized with his own data
Coming Soon
We are about to launch our first human trial in partnership with the Caen hospital (Normandy, France).